Viyash Scientific Limited (BOM:512529)
India · Delayed Price · Currency is INR 197.35
+6.55 (3.43%)
At close: Mar 10, 2026
Viyash Scientific Market Cap
Viyash Scientific has a market cap or net worth of 83.27 billion as of March 10, 2026. Its market cap has increased by 127.54% in one year.
Market Cap
83.27B
Enterprise Value
88.24B
Revenue
18.17B
Ranking
n/a
PE Ratio
49.92
Stock Price
197.35
Market Cap Chart
Since January 5, 2005, Viyash Scientific's market cap has increased from 347.75M to 83.27B, an increase of 23,846.06%. That is a compound annual growth rate of 29.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 83.27B | -8.18% |
| Dec 31, 2025 | 90.70B | 106.22% |
| Dec 31, 2024 | 43.98B | 55.47% |
| Dec 29, 2023 | 28.29B | 29.89% |
| Dec 30, 2022 | 21.78B | -45.17% |
| Dec 31, 2021 | 39.72B | -4.29% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| J. B. Chemicals & Pharmaceuticals | 329.34B |
| AstraZeneca Pharma India | 218.50B |
| Granules India | 142.93B |
| Jubilant Pharmova | 129.48B |
| Caplin Point Laboratories | 126.61B |
| Rubicon Research | 126.17B |
| CORONA Remedies | 96.72B |
| Sanofi India | 87.18B |